• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

后基因组时代的人类疾病分类:人类病理生物学的复杂系统方法

Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.

作者信息

Loscalzo Joseph, Kohane Isaac, Barabasi Albert-Laszlo

机构信息

Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Mol Syst Biol. 2007;3:124. doi: 10.1038/msb4100163. Epub 2007 Jul 10.

DOI:10.1038/msb4100163
PMID:17625512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1948102/
Abstract

Contemporary classification of human disease derives from observational correlation between pathological analysis and clinical syndromes. Characterizing disease in this way established a nosology that has served clinicians well to the current time, and depends on observational skills and simple laboratory tools to define the syndromic phenotype. Yet, this time-honored diagnostic strategy has significant shortcomings that reflect both a lack of sensitivity in identifying preclinical disease, and a lack of specificity in defining disease unequivocally. In this paper, we focus on the latter limitation, viewing it as a reflection both of the different clinical presentations of many diseases (variable phenotypic expression), and of the excessive reliance on Cartesian reductionism in establishing diagnoses. The purpose of this perspective is to provide a logical basis for a new approach to classifying human disease that uses conventional reductionism and incorporates the non-reductionist approach of systems biomedicine.

摘要

当代人类疾病分类源于病理分析与临床综合征之间的观察性关联。以这种方式对疾病进行特征描述建立了一种疾病分类学,它在当前一直很好地服务于临床医生,并且依赖观察技能和简单的实验室工具来定义综合征型表型。然而,这种历史悠久的诊断策略存在重大缺陷,既反映出在识别临床前疾病方面缺乏敏感性,也反映出在明确界定疾病方面缺乏特异性。在本文中,我们关注后一个局限性,将其视为许多疾病不同临床表现(可变表型表达)以及在确立诊断时过度依赖笛卡尔还原论的一种反映。这一观点的目的是为一种新的人类疾病分类方法提供逻辑基础,该方法采用传统还原论并纳入系统医学的非还原论方法。

相似文献

1
Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.后基因组时代的人类疾病分类:人类病理生物学的复杂系统方法
Mol Syst Biol. 2007;3:124. doi: 10.1038/msb4100163. Epub 2007 Jul 10.
2
Systems biology and the future of medicine.系统生物学与未来医学。
Wiley Interdiscip Rev Syst Biol Med. 2011 Nov-Dec;3(6):619-27. doi: 10.1002/wsbm.144. Epub 2011 Feb 24.
3
Systems biology and personalized medicine: a network approach to human disease.系统生物学与个性化医学:人类疾病的网络研究方法。
Proc Am Thorac Soc. 2011 May;8(2):196-8. doi: 10.1513/pats.201006-041MS.
4
Evaluating technologies for classification and prediction in medicine.评估医学中用于分类和预测的技术。
Stat Med. 2005 Dec 30;24(24):3687-96. doi: 10.1002/sim.2431.
5
Revisiting the Krogh Principle in the post-genome era: Caenorhabditis elegans as a model system for integrative physiology research.在后基因组时代重新审视克罗格原理:秀丽隐杆线虫作为整合生理学研究的模型系统。
J Exp Biol. 2007 May;210(Pt 9):1622-31. doi: 10.1242/jeb.000125.
6
Using a systems-based approach to overcome reductionist strategies in the development of diagnostics.采用基于系统的方法克服诊断开发中的还原论策略。
Expert Rev Mol Diagn. 2013 Nov;13(8):895-905. doi: 10.1586/14737159.2013.846828. Epub 2013 Oct 21.
7
Systems Biology: A Powerful Tool for Drug Development.系统生物学:药物研发的有力工具。
Curr Top Med Chem. 2018;18(20):1745-1754. doi: 10.2174/1568026618666181025113226.
8
Neuropharmacology beyond reductionism - A likely prospect.超越还原论的神经药理学——一个可能的前景。
Biosystems. 2016 Mar;141:1-9. doi: 10.1016/j.biosystems.2015.11.010. Epub 2015 Dec 23.
9
Integrative genomics--a basic and essential tool for the development of molecular medicine.整合基因组学——分子医学发展的一项基础且必不可少的工具。
Acta Pol Pharm. 2008 Nov-Dec;65(6):621-4.
10
Systems biology and its application to the understanding of neurological diseases.系统生物学及其在理解神经疾病方面的应用。
Ann Neurol. 2009 Feb;65(2):124-39. doi: 10.1002/ana.21634.

引用本文的文献

1
The Experiences of Patients With Rare Diseases in Pennsylvania: A Community-Based Study.宾夕法尼亚州罕见病患者的经历:一项基于社区的研究。
Public Health Rep. 2025 Sep 7:333549251362711. doi: 10.1177/00333549251362711.
2
"Snip, snip, cure"? Philosophical, legal and biomedical perspectives on novel somatic genomic therapies.“剪一剪,治百病”?关于新型体细胞基因组疗法的哲学、法律和生物医学视角
Med Health Care Philos. 2025 Sep;28(3):425-445. doi: 10.1007/s11019-025-10284-5. Epub 2025 Aug 11.
3
Evaluating the usefulness of C5 and C5AR1 as genetic biomarkers of IgA-mediated vasculitis.

本文引用的文献

1
The human disease network.人类疾病网络。
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90. doi: 10.1073/pnas.0701361104. Epub 2007 May 14.
2
Hubs in biological interaction networks exhibit low changes in expression in experimental asthma.生物相互作用网络中的枢纽在实验性哮喘中表现出低表达变化。
Mol Syst Biol. 2007;3:98. doi: 10.1038/msb4100138. Epub 2007 Apr 17.
3
A robustness-based approach to systems-oriented drug design.一种基于稳健性的面向系统的药物设计方法。
评估C5和C5AR1作为IgA介导的血管炎遗传生物标志物的有用性。
Mol Med. 2025 Jul 27;31(1):267. doi: 10.1186/s10020-025-01313-3.
4
CRISP: A causal relationships-guided deep learning framework for advanced ICU mortality prediction.CRISP:一种用于重症监护病房(ICU)晚期死亡率预测的因果关系引导深度学习框架。
BMC Med Inform Decis Mak. 2025 Apr 15;25(1):165. doi: 10.1186/s12911-025-02981-1.
5
The 11th International Conference on cGMP 2024: recent trends and developments in cGMP research -meeting report.2024年第11届国际cGMP会议:cGMP研究的最新趋势与进展——会议报告
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 7. doi: 10.1007/s00210-025-04059-1.
6
Healthy lives and well-being for all at all ages: expanding representations of determinants of health within systems dynamics and integrated assessment models.全年龄段所有人的健康生活与福祉:在系统动力学和综合评估模型中拓展健康决定因素的表征
Sustain Earth. 2023;6(1):15. doi: 10.1186/s42055-023-00064-5. Epub 2023 Dec 5.
7
approaches open new horizons in major depressive disorder: from biomarkers to precision medicine.治疗方法为重度抑郁症开拓新视野:从生物标志物到精准医学。
Front Psychiatry. 2024 Jun 13;15:1422939. doi: 10.3389/fpsyt.2024.1422939. eCollection 2024.
8
Developing and comparing deep learning and machine learning algorithms for osteoporosis risk prediction.开发并比较用于骨质疏松症风险预测的深度学习和机器学习算法。
Front Artif Intell. 2024 Jun 11;7:1355287. doi: 10.3389/frai.2024.1355287. eCollection 2024.
9
Ayurgenomics-based frameworks in precision and integrative medicine: Translational opportunities.精准与整合医学中基于阿育吠陀基因组学的框架:转化机遇。
Camb Prism Precis Med. 2023 Jun 15;1:e29. doi: 10.1017/pcm.2023.15. eCollection 2023.
10
Redox organization of living systems.生命系统的氧化还原组织
Free Radic Biol Med. 2024 May 1;217:179-189. doi: 10.1016/j.freeradbiomed.2024.03.008. Epub 2024 Mar 14.
Nat Rev Drug Discov. 2007 Mar;6(3):202-10. doi: 10.1038/nrd2195. Epub 2007 Feb 23.
4
A network biology approach to prostate cancer.一种用于前列腺癌的网络生物学方法。
Mol Syst Biol. 2007;3:82. doi: 10.1038/msb4100125. Epub 2007 Feb 13.
5
An obesity-associated gut microbiome with increased capacity for energy harvest.一种与肥胖相关的肠道微生物群,其能量获取能力增强。
Nature. 2006 Dec 21;444(7122):1027-31. doi: 10.1038/nature05414.
6
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.解析镰状细胞病:重新评估溶血在临床亚表型发展中的作用。
Blood Rev. 2007 Jan;21(1):37-47. doi: 10.1016/j.blre.2006.07.001. Epub 2006 Nov 7.
7
Global systems biology, personalized medicine and molecular epidemiology.全球系统生物学、个性化医疗与分子流行病学。
Mol Syst Biol. 2006;2:52. doi: 10.1038/msb4100095. Epub 2006 Oct 3.
8
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.激素替代疗法影响基因表达谱并与乳腺癌预后相关:一项队列研究。
BMC Med. 2006 Jun 30;4:16. doi: 10.1186/1741-7015-4-16.
9
Molecular diagnosis of Burkitt's lymphoma.伯基特淋巴瘤的分子诊断
N Engl J Med. 2006 Jun 8;354(23):2431-42. doi: 10.1056/NEJMoa055759.
10
A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.人类遗传性共济失调和浦肯野细胞变性疾病的蛋白质-蛋白质相互作用网络。
Cell. 2006 May 19;125(4):801-14. doi: 10.1016/j.cell.2006.03.032.